Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
KONINKLIJKE PHILIPS NV
Exor N.V. updated its beneficial ownership stake in Koninklijke Philips NV through a Schedule 13D/A filing submitted on August 21, 2026. The filing details the changes in shareholding and voting interests held by Exor N.V. in the company.…more
KONINKLIJKE PHILIPS NV
필립스는 2026년 2분기 매출 44억 유로를 기록하며 전년 대비 4%의 비교 가능한 매출 성장을 달성했습니다. 미국 관세 환급금 수령에 힘입어 연간 조정 EBITA 마진 및 잉여 현금 흐름 가이던스를 상향 조정했습니다.…more
1 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Philips Launches 5-Year, EUR 27.6M Cardiovascular Research Project
Philips has partnered with 42 organizations across 17 countries to conduct a five-year cardiovascular research project involving over 14,000 patients. While the initiative aims to improve personalized cardiac care, it is a long-term research collaboration rather than an immediate revenue-generating event.…more
●●●●●●●● ●●●●● ●●●●●●
Royal Philips has launched the five-year EXIT-CVD research project, uniting 42 partners across 17 countries to conduct 22 clinical studies. While the initiative aims to advance cardiovascular diagnostic and treatment technologies, it is a long-term research effort with no immediate impact on financial performance.…more
●●●●●●●● ●●●●● ●●●●●●
The FDA is aware of a letter from Philips Ultrasound regarding updated use instructions for its Lumify diagnostic systems following reports of 4 deaths and 8 serious injuries. This safety issue poses a significant risk to the company's reputation and potential liability.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.